Nature-derived microbiota exposure as a novel immunomodulatory approach.
Nurminen N, Lin J, Grönroos M, Puhakka R, Kramna L, Vari HK, Viskari H, Oikarinen S, Roslund M, Parajuli A, Tyni I, Cinek O, Laitinen O, Hyöty H, Sinkkonen A.
Nurminen N, et al.
Future Microbiol. 2018 Jun 1;13:737-744. doi: 10.2217/fmb-2017-0286. Epub 2018 May 17.
Future Microbiol. 2018.
PMID: 29771153
Clinical Trial.